Muller JM - Search Results

1

Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT 29).

Luis J, Muller JM, Abadie B, Martin JM, Marvaldi J, Pichon J. Luis J, et al. Among authors: muller jm. Eur J Biochem. 1986 May 2;156(3):631-6. doi: 10.1111/j.1432-1033.1986.tb09624.x. Eur J Biochem. 1986. PMID: 3009188 Free article.

2

Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29).

Muller JM, Luis J, Fantini J, Abadie B, Giannellini F, Marvaldi J, Pichon J. Muller JM, et al. Eur J Biochem. 1985 Sep 2;151(2):411-7. doi: 10.1111/j.1432-1033.1985.tb09117.x. Eur J Biochem. 1985. PMID: 2992966 Free article.

3

Characterization of the vasoactive intestinal peptide (VIP) binding sites: a biochemical and an immunological approach.

Marvaldi J, Luis J, Muller JM, el Battari A, Fantini J, Martin JM, Abadie B, Tirard A, Pichon J. Marvaldi J, et al. Among authors: muller jm. Peptides. 1986;7 Suppl 1:137-45. doi: 10.1016/0196-9781(86)90176-2. Peptides. 1986. PMID: 3018691

4

Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29).

Muller JM, el Battari A, Ah-Kye E, Luis J, Ducret F, Pichon J, Marvaldi J. Muller JM, et al. Eur J Biochem. 1985 Oct 1;152(1):107-14. doi: 10.1111/j.1432-1033.1985.tb09169.x. Eur J Biochem. 1985. PMID: 4043073 Free article.

5

HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.

Marchis-Mouren G, Martin JM, Luis J, el Battari A, Muller JM, Marvaldi J, Pichon J. Marchis-Mouren G, et al. Among authors: muller jm. Biochimie. 1988 May;70(5):663-71. doi: 10.1016/0300-9084(88)90251-9. Biochimie. 1988. PMID: 2844304 Review.

6

Modification of HT 29 cell response to the vasoactive intestinal peptide (VIP) by membrane fluidization.

el Battari A, Ah-Kye E, Muller JM, Sari H, Marvaldi J. el Battari A, et al. Among authors: muller jm. Biochimie. 1985 Dec;67(12):1217-23. doi: 10.1016/s0300-9084(85)80130-9. Biochimie. 1985. PMID: 3006797

7

The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature.

el Battari A, Luis J, Martin JM, Fantini J, Muller JM, Marvaldi J, Pichon J. el Battari A, et al. Among authors: muller jm. Biochem J. 1987 Feb 15;242(1):185-91. doi: 10.1042/bj2420185. Biochem J. 1987. PMID: 3036083 Free PMC article.

8

Evidence for an ectophosvitin kinase activity that phosphorylates a 123 kDa endogenous substrate on a human colonic adenocarcinoma cell (HT 29).

Fantini J, Muller JM, Abadie B, el Battari A, Marvaldi J, Tirard A. Fantini J, et al. Among authors: muller jm. Eur J Cell Biol. 1987 Jun;43(3):342-7. Eur J Cell Biol. 1987. PMID: 3622524

9

Anti-cell surface monoclonal antibodies which antagonize the action of VIP in a human adenocarcinoma cell line (HT 29 cells).

Pichon J, Hirn M, Muller JM, Mangeat P, Marvaldi J. Pichon J, et al. Among authors: muller jm. EMBO J. 1983;2(7):1017-22. doi: 10.1002/j.1460-2075.1983.tb01539.x. EMBO J. 1983. PMID: 6313348 Free PMC article.

10

[The intestinal immune system. The VIP receptor on T lymphocytes: a new marker of differentiation?].

Fantini J, Tirard A, el Battari A, Luis J, Muller JM, Pichon J, Marvaldi J. Fantini J, et al. Among authors: muller jm. Gastroenterol Clin Biol. 1985 Dec;9(12):929-35. Gastroenterol Clin Biol. 1985. PMID: 3007259 Review. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

608 results

Search Page

Filters